Meloxicam and Promacta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meloxicam (meloxicam) and Promacta (eltrombopag olamine). Common drug interactions include pubis fracture among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Meloxicam and Promacta. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,017 Meloxicam users. Check the latest studies of Meloxicam.

What is Promacta?

Promacta has active ingredients of eltrombopag olamine. It is often used in idiopathic thrombocytopenic purpura (itp). eHealthMe is studying from 17,758 Promacta users. Check the latest studies of Promacta.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

19 people who take Meloxicam and Promacta together, and have interactions are studied.

Meloxicam and Promacta drug interactions.

What are the common drug interactions of Meloxicam and Promacta, by gender? *:

female:

Pubis fracture
Syncope (loss of consciousness with an inability to maintain postural tone)
Arthralgia (joint pain)
Febrile neutropenia (fever with reduced white blood cells)
Loss of consciousness
Abdominal pain upper
Appendicitis (inflammation of the appendix)
Asthenia (weakness)
Culture urine positive
Death

male:

Diarrhoea
Epistaxis (bleed from the nose)
Myofascial pain syndrome (a painful condition that affects the muscles and the sheath of the tissue)
Platelet count decreased
Body temperature increased
Death
Dysphagia (a condition in which swallowing is difficult or painful)
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
Liver disorder (liver diseases)

What are the common drug interactions of Meloxicam and Promacta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Fall
Pubis fracture
Abdominal pain upper
Appendicitis (inflammation of the appendix)
Asthenia (weakness)
Culture urine positive
Death
Decreased appetite
Escherichia infection (bacterial infection by escherichia coli)
Escherichia test positive

What are the existing conditions these people have? *

Thrombocytopenia (decrease of platelets in blood): 4 people, 21.05%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 15.79%
Hepatitis C: 3 people, 15.79%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 10.53%
Vitamin B12 Decreased: 1 person, 5.26%
Hypersensitivity: 1 person, 5.26%
Blood Pressure Abnormal: 1 person, 5.26%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.26%
Heart Rate Irregular: 1 person, 5.26%
High Blood Pressure: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and Promacta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously